Clinical Trials Logo

Clinical Trial Summary

Gastrointestinal bleeding is a common complication of liver cirrhosis which caused by esophageal and gastric varices. The risk of bleeding from gastric varices is relatively low. However, the bleeding is usually significant and severe. Current guidelines recommend endoscopic glue injection as the first line of treatment for gastric variceal bleeding. Although this technique has been shown to be effective, it is associated with many severe adverse events including systemic embolization, fever, chest pain, and even death. The rate of hemostasis has been reported to be as high as 91-100% but the rebleeding rate from gastric varices still present. Endoscopic ultrasound (EUS) guided therapy has recently been introduced as a more effective and safer option than endoscopic therapy for gastric varices. EUS-guided therapy includes EUS guided Cyanoacrylate injection alone or in combination with EUS-guided coiling. It offers the advantage of directly visualizing the varices and delivering targeted therapy. A standard endoscopic examination only allows the evaluation of superficial varices. The use of Endoscopic ultrasound facilitates evaluation of peri-gastric and perforating vessels, which are directly involved in variceal development. EUS also facilitates accurate placement of the coil and preserves the naturally formed splenorenal shunt. Balloon-occluded retrograde transvenous obliteration(BRTO) has been reported to achieve satisfactory bleeding control rates for isolated gastric varices with High hemostasis rates and low rebleeding rate. Despite all these promising results, there are scarce studies describing and comparing the efficacy of EUS-guided therapy and BRTO in patients with gastric varices. Further prospective comparative studies are needed.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05500625
Study type Interventional
Source Assiut University
Contact Sara Mahrous, assistant lecturer
Phone +21009605484
Email sarah.3000@hotmail.com
Status Not yet recruiting
Phase N/A
Start date August 30, 2022
Completion date January 30, 2025

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05515861 - Evaluation of EUS in Preventing Rebleeding After Endoscopic Cyanoacrylate Injection for Gastric Varices N/A
Completed NCT04828369 - Efficacy and Safety of EUS-Guided Therapy Versus BRTO for Gastric Varices With Shunt
Recruiting NCT05614999 - The Validation and Efficacy of Varix Trainer as a Training Device Esophagogastroduodenoscopy (a Multicenter Study) N/A
Completed NCT03155256 - Treatment of Gastric Varices Using EUS Guided Techniques N/A
Recruiting NCT03171805 - The Use of Propranolol for the Prevention of Worsening of Esophageal Varices in Patients With Isolated Gastric Varices N/A
Completed NCT03748563 - Accuracy of Magnetically Maneuvered Capsule Endoscopy for Detection of EGV in Patients With Cirrhosis N/A
Recruiting NCT04140578 - Antibiotic Prophylaxis in Patients Undergoing GVO Phase 4
Recruiting NCT04222127 - EUS-guided Obturation of High Risk Gastric Varices Versus Standard Endoscopic Treatment N/A
Recruiting NCT04075760 - EUS-guided Combined Therapy Versus Beta Blocker Therapy in Primary Prophylaxis o GOV II and IGV I N/A
Not yet recruiting NCT03853720 - Combined and Simultaneous Approach for the Treatment of High-risk Gastric Varices Using B-RTO and EVO N/A